GLOBUS MEDICAL, INC. Depreciation
GLOBUS MEDICAL, INC. (GMED) reported Depreciation of $40.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- GLOBUS MEDICAL, INC. depreciation for the quarter ending 2026-06-30 was $40.52M, a 0.21% increase year-over-year.
- GLOBUS MEDICAL, INC. depreciation for the quarter ending 2026-03-31 was $40.59M, a 8.92% increase year-over-year.
- GLOBUS MEDICAL, INC. depreciation for the quarter ending 2025-12-31 was $40.29M, a 5.15% increase year-over-year.
- GLOBUS MEDICAL, INC. depreciation for the quarter ending 2025-09-30 was $41.28M, a 11.96% increase year-over-year.
- GLOBUS MEDICAL, INC. depreciation for fiscal 2025 was $159.29M, a 18.30% increase from fiscal 2024.
- GLOBUS MEDICAL, INC. depreciation for fiscal 2024 was $134.65M, a 43.70% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. depreciation for fiscal 2023 was $93.70M, a 85.49% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. depreciation for fiscal 2022 was $50.52M, a 1.61% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.52M 10-Q · filed 2026-08-06 | $81.12M 10-Q · filed 2026-08-06 | $121.41M derived: sum of 3 quarters · filed 2026-08-06 | $162.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $40.59M 10-Q · filed 2026-05-07 | $80.88M derived: sum of 2 quarters · filed 2026-05-07 | $122.17M derived: sum of 3 quarters · filed 2026-05-07 | $162.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $40.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $81.57M derived: sum of 2 quarters · filed 2026-02-24 | $122.02M derived: sum of 3 quarters · filed 2026-08-06 | $159.29M 10-K · filed 2026-02-24 |
| 2025-09-30 | $41.28M 10-Q · filed 2025-11-06 | $81.73M derived: sum of 2 quarters · filed 2026-08-06 | $119.00M 10-Q · filed 2025-11-06 | $157.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $40.44M 10-Q · filed 2026-08-06 | $77.71M 10-Q · filed 2026-08-06 | $116.03M derived: sum of 3 quarters · filed 2026-08-06 | $152.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $37.27M 10-Q · filed 2026-05-07 | $75.59M derived: sum of 2 quarters · filed 2026-05-07 | $112.46M derived: sum of 3 quarters · filed 2026-05-07 | $146.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $38.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $75.19M derived: sum of 2 quarters · filed 2026-02-24 | $109.07M derived: sum of 3 quarters · filed 2026-02-24 | $134.65M 10-K · filed 2026-02-24 |
| 2024-09-30 | $36.87M 10-Q · filed 2025-11-06 | $70.75M derived: sum of 2 quarters · filed 2025-11-06 | $96.33M 10-Q · filed 2025-11-06 | $139.38M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $33.88M 10-Q · filed 2025-08-07 | $59.46M 10-Q · filed 2025-08-07 | $102.50M derived: sum of 3 quarters · filed 2026-02-24 | $126.13M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $25.58M 10-Q · filed 2025-05-08 | $68.62M derived: sum of 2 quarters · filed 2026-02-24 | $92.25M derived: sum of 3 quarters · filed 2026-02-24 | $105.78M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $43.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $66.67M derived: sum of 2 quarters · filed 2026-02-24 | $80.19M derived: sum of 3 quarters · filed 2026-02-24 | $93.70M 10-K · filed 2026-02-24 |
| 2023-09-30 | $23.63M 10-Q · filed 2024-11-05 | $37.16M derived: sum of 2 quarters · filed 2024-11-05 | $50.66M 10-Q · filed 2024-11-05 | $63.07M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $13.53M 10-Q · filed 2024-08-06 | $27.04M 10-Q · filed 2024-08-06 | $39.44M derived: sum of 3 quarters · filed 2025-02-20 | $52.69M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $13.51M 10-Q · filed 2024-05-07 | $25.91M derived: sum of 2 quarters · filed 2025-02-20 | $39.16M derived: sum of 3 quarters · filed 2025-02-20 | $51.70M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $25.66M derived: sum of 2 quarters · filed 2025-02-20 | $38.19M derived: sum of 3 quarters · filed 2025-02-20 | $50.52M 10-K · filed 2025-02-20 |
| 2022-09-30 | $13.25M 10-Q · filed 2023-11-07 | $25.79M derived: sum of 2 quarters · filed 2023-11-07 | $38.11M 10-Q · filed 2023-11-07 | $50.39M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $12.54M 10-Q · filed 2023-08-03 | $24.86M 10-Q · filed 2023-08-03 | $37.13M derived: sum of 3 quarters · filed 2024-02-21 | $49.31M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $12.32M 10-Q · filed 2023-05-04 | $24.60M derived: sum of 2 quarters · filed 2024-02-21 | $36.78M derived: sum of 3 quarters · filed 2024-02-21 | $51.28M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $12.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $24.45M derived: sum of 2 quarters · filed 2024-02-21 | $38.96M derived: sum of 3 quarters · filed 2024-02-21 | $51.34M 10-K · filed 2024-02-21 |
| 2021-09-30 | $12.18M 10-Q · filed 2022-11-08 | $26.68M derived: sum of 2 quarters · filed 2022-11-08 | $39.07M 10-Q · filed 2022-11-08 | $51.19M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $14.51M 10-Q · filed 2022-08-04 | $26.89M 10-Q · filed 2022-08-04 | $39.01M derived: sum of 3 quarters · filed 2023-02-21 | $51.16M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $12.38M 10-Q · filed 2022-05-10 | $24.50M derived: sum of 2 quarters · filed 2023-02-21 | $36.65M derived: sum of 3 quarters · filed 2023-02-21 | $47.64M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $24.27M derived: sum of 2 quarters · filed 2023-02-21 | $35.25M derived: sum of 3 quarters · filed 2023-02-21 | $46.04M 10-K · filed 2023-02-21 |
| 2020-09-30 | $12.15M 10-Q · filed 2021-11-04 | $23.14M derived: sum of 2 quarters · filed 2021-11-04 | $33.92M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $10.99M 10-Q · filed 2021-08-04 | $21.78M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $10.79M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $38.92M 10-K · filed 2022-02-17 | |||
| 2018-12-31 | $32.04M 10-K · filed 2021-02-17 | |||
| 2017-12-31 | $34.16M 10-K/A · filed 2020-03-02 | |||
| 2016-12-31 | $35.29M 10-K · filed 2019-02-21 | |||
| 2015-12-31 | $22.52M 10-K · filed 2018-02-22 | |||
| 2014-12-31 | $21.04M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $18.87M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $17.64M 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $16.88M 10-K · filed 2014-03-14 | |||
| 2010-12-31 | $15.20M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |